Viewing Study NCT00010192


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2026-02-06 @ 6:04 AM
Study NCT ID: NCT00010192
Status: COMPLETED
Last Update Posted: 2013-06-06
First Post: 2001-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Adult Acute Lymphoblastic Leukemia View
None Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue View
None Nodal Marginal Zone B-cell Lymphoma View
None Noncontiguous Stage II Adult Burkitt Lymphoma View
None Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma View
None Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma View
None Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma View
None Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma View
None Noncontiguous Stage II Adult Lymphoblastic Lymphoma View
None Noncontiguous Stage II Grade 1 Follicular Lymphoma View
None Noncontiguous Stage II Grade 2 Follicular Lymphoma View
None Noncontiguous Stage II Grade 3 Follicular Lymphoma View
None Noncontiguous Stage II Mantle Cell Lymphoma View
None Noncontiguous Stage II Marginal Zone Lymphoma View
None Noncontiguous Stage II Small Lymphocytic Lymphoma View
None Recurrent Adult Acute Lymphoblastic Leukemia View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Adult Diffuse Mixed Cell Lymphoma View
None Recurrent Adult Diffuse Small Cleaved Cell Lymphoma View
None Recurrent Adult Immunoblastic Large Cell Lymphoma View
None Recurrent Adult Lymphoblastic Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Marginal Zone Lymphoma View
None Recurrent Small Lymphocytic Lymphoma View
None Splenic Marginal Zone Lymphoma View
None Stage III Adult Burkitt Lymphoma View
None Stage III Adult Diffuse Large Cell Lymphoma View
None Stage III Adult Diffuse Mixed Cell Lymphoma View
None Stage III Adult Diffuse Small Cleaved Cell Lymphoma View
None Stage III Adult Immunoblastic Large Cell Lymphoma View
None Stage III Adult Lymphoblastic Lymphoma View
None Stage III Grade 1 Follicular Lymphoma View
None Stage III Grade 2 Follicular Lymphoma View
None Stage III Grade 3 Follicular Lymphoma View
None Stage III Mantle Cell Lymphoma View
None Stage III Marginal Zone Lymphoma View
None Stage III Small Lymphocytic Lymphoma View
None Stage IV Adult Burkitt Lymphoma View
None Stage IV Adult Diffuse Large Cell Lymphoma View
None Stage IV Adult Diffuse Mixed Cell Lymphoma View
None Stage IV Adult Diffuse Small Cleaved Cell Lymphoma View
None Stage IV Adult Immunoblastic Large Cell Lymphoma View
None Stage IV Adult Lymphoblastic Lymphoma View
None Stage IV Grade 1 Follicular Lymphoma View
None Stage IV Grade 2 Follicular Lymphoma View
None Stage IV Grade 3 Follicular Lymphoma View
None Stage IV Mantle Cell Lymphoma View
None Stage IV Marginal Zone Lymphoma View
None Stage IV Small Lymphocytic Lymphoma View
Keywords: